Qi-li-sheng Immunity Oral Solution Cooperation and Execution ContractShanghai Yutong Pharma, Inc • February 16th, 2006
Due to Jia side already had National Technique and Hygiene license permit by China relevant department for Qi-li-sheng immunity oral solution (Product Code Wei-shi-jian-zi No.114); Yi side had a thorough knowledge and understanding the product through tracking, examinations and testing, and certified this technique would have essential efficacy for the society and economy. If there were technique support, legal representative and necessary fund, they would do development cooperation with Jia side. After full consultation, under mutual benefit, equality, self-imposed, credit principle, Jia side and Yi side signed this contract together, and would fulfill their respective contract obligation.
Medicines Distributor of Beijing ContractShanghai Yutong Pharma, Inc • August 21st, 2006 • Dairy products
Based on the mutually beneficially principle, both sides equally and voluntarily signed an agreement that Jia side trust Yi side with above products distributing in Beijing, detailed as below:
AGREEMENT FOR THE PURCHASE OF COMMON STOCKAgreement for the Purchase of Common Stock • February 16th, 2006 • Shanghai Yutong Pharma, Inc • New York
THIS COMMON STOCK PURCHASE AGREEMENT, (the “AGREEMENT”) made this 3rd day of June, 2005, by and among Shanghai Yutong Pharmaceuticals, Inc. No. 2020 Huqingping Road Qingpu District Shanghai, 201702 China, (“Buyer”) and Western Bankers Capital (“Seller”), a shareholder owning a majority of the shares of common stock of Child Vision, Inc Corporation (“CHVI” or the “Company”) with an office located at 126 East 83rd St. Suite 3B New York, NY 10028 USA .
